[1] Xie LY, Zhang ML, Dong BJ, et al. Improved refractory wound healing with administration of acidic fibroblast growth factor in diabetic rats [J]. Diabetes Research and Clinical Practice, 2011, 93(3):396- 403.
[2] Ravat F, Le-Floch R, Vinsonneau C. Antibiotics and the burn patient [J]. Burns, 2011, 37(1):16-26.
[3] Overhage J, Campisano A, Bains M, et al. Human host defence peptide LL-37 prevents bacterial biofilm formation [J]. The Journal of Immunology, 2011, 186(9):5497-5505.
[4] Sun CL, Zhang FZ, Li P, et al. LL-37 expression in the skin in systemic lupus erythematosus [J]. Lupus, 2011, 20(9):904-911.
[5] Ching YH, Sutton TL, Pierpont YN, et al. The use of growth factors and other humoral agents to accelerate and enhance burn wound healing [J]. Eplasty, 2011, 11 :e41.
[6] Son YJ, Bae JY, Chong SH, et al. Expression, high cell density culture and purification of recombinant EC-SOD in Escherichia coli[J]. Appl Biochem Biotechnol, 2010, 162(6):1585-1598.
[7] Eiberle MK, Jungbauer A. Technical refolding of proteins :Do we have freedom to operate?[J]. Biotechnol J, 2010, 5(6):547- 559.
[8] Tsumoto K, Umetsu M, Kumagai I, et al. Role of arginine in protein refolding, solubilization, and purification[J]. Biotechnol Prog, 2004, 20(5):1301-1308.
[9] Arakawa T, Ejima D, Tsumoto K, et al. Suppression of protein interactions by arginine :a proposed mechanism of the arginine effects[J]. Biophys Chem, 2007, 127(1-2):1-8.
[10] Das U, Hariprasad G, Ethayathulla AS, et al. Inhibition of protein aggregation :supramolecular assemblies of arginine hold the key[J]. PLoS One, 2007, 2(11):e1176. |